CHMP supports expanded approval for epoetin alfa productsJuly 31, 2018AnemiaPharmacyMyelodysplastic Syndrome
CHMP backs 2 biosimilar pegfilgrastim productsJuly 31, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
FDA approves drug for IDH1-mutated AMLJuly 23, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Health Canada expands approval of obinutuzumabJuly 10, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
EC approves new use, formulation of dasatinibJuly 6, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
CHMP recommends CAR T for ALL, DLBCLJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends CAR T for DLBCL, PMBCLJuly 2, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
CHMP backs expanded approval of tocilizumabJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
EC grants blinatumomab full approvalJune 21, 2018Leukemia, Myelodysplasia, TransplantationPharmacyALL
FDA grants pembrolizumab accelerated approval for PMBCLJune 14, 2018Lymphoma & Plasma Cell DisordersPharmacyAggressive Lymphomas
